Design, synthesis and structure-activity relationship evaluation of novel LpxC inhibitors as Gram-negative antibacterial agents
作者:Shi Ding、Rui-Yang Dai、Wen-Ke Wang、Qiao Cao、Le-Fu Lan、Xian-Li Zhou、Yu-She Yang
DOI:10.1016/j.bmcl.2017.12.005
日期:2018.1
LpxC inhibitors are new-type antibacterial agents developed in the last twenty years, mainly against Gram-negative bacteria infections. To develop novel LpxC inhibitors with good antibacterial activities and biological metabolism, we summarized the basic skeleton of reported LpxC inhibitors, designed and synthesized several series of compounds and tested their antibacterial activities against Escherichial
LpxC抑制剂是最近二十年来开发的新型抗菌剂,主要针对革兰氏阴性细菌感染。为了开发具有良好抗菌活性和生物代谢的新型LpxC抑制剂,我们总结了已报道的LpxC抑制剂的基本骨架,设计并合成了一系列化合物,并测试了它们在体外对大肠杆菌和铜绿假单胞菌的抗菌活性。本文已讨论了结构活动关系。YDL-2,YDL-5,YDL-8,YDL-14,YDL-20 – YDL-23的代谢稳定性 已经在肝微粒体中评价了β-氨基丁酸,这表明在设计LpxC抑制剂中,2-氨基异丙基可能是比2-羟基乙基优选的结构。